-
公开(公告)号:EP4426306A1
公开(公告)日:2024-09-11
申请号:EP22802517.7
申请日:2022-10-04
IPC分类号: A61K31/519 , A61P21/00 , A61K39/395 , A61K9/00 , A61K47/10 , A61K47/12 , A61K47/18 , A61K47/22 , A61K47/26 , A61K39/00 , C07K16/22
CPC分类号: A61K31/519 , A61P21/00 , A61K9/0095 , A61K47/26 , A61K47/10 , A61K47/183 , A61K47/22 , A61K47/12 , C07K16/22 , A61K2039/50520130101 , A61K39/395
-
公开(公告)号:EP4422599A1
公开(公告)日:2024-09-04
申请号:EP22809383.7
申请日:2022-10-24
申请人: Farmalider, S.A.
发明人: SANZ MENÉNDEZ, Nuria , MUÑOZ RUIZ, Ángel , SANTÉ SERNA, Luis Narciso , PORTOLÉS PÉREZ, Antonio , VARGAS CASTRILLÓN, Emilio , RUBIO MENCO, Guillermo , HORCAJADA CÓRDOBA, Raquel , DUART GONZÁLEZ, Ester , IGLESIAS SÁNCHEZ, José Carlos , GÓMEZ CALVO, Antonia
-
公开(公告)号:EP4397373A3
公开(公告)日:2024-09-04
申请号:EP24176682.3
申请日:2012-02-03
发明人: BANNISTER, Robin Mark , BREW, John , DILLY, Suzanne Jane , STOLOFF, Gregory Alan , CAPARROS-WANDERLEY, Wilson
摘要: The present specification discloses pharmaceutical compositions comprising a peroxisome proliferatoractivated receptor (PPAR) agonist.
-
公开(公告)号:EP4420724A2
公开(公告)日:2024-08-28
申请号:EP24181935.8
申请日:2019-11-01
发明人: HAYAMA, Tetsuo , TAKAHASHI, Tomohiro , OMURA, Tomoyuki , HAYASHI, Kouji , MATSUDA, Munetomo , MIYAZAWA, Tadashi
IPC分类号: A61P25/28
CPC分类号: A61K47/32 , A61K9/10 , A61K47/36 , A61K31/4152 , A61K47/38 , A61P25/28 , A61P21/02 , A61P21/00 , A61K9/0095
摘要: This invention provides with an edaravone suspension for oral administration having excellent bioavailability. It is expected that burden on ALS patients and care workers can be reduced thereby.
-
公开(公告)号:EP4408419A1
公开(公告)日:2024-08-07
申请号:EP22790054.5
申请日:2022-09-30
申请人: Ferring B.V.
CPC分类号: A61K9/0095 , A61K47/44 , A61K47/22 , A61K31/4166 , A61K9/107 , A61K47/14 , A61P35/00
-
公开(公告)号:EP4408200A1
公开(公告)日:2024-08-07
申请号:EP22783349.8
申请日:2022-09-26
IPC分类号: A23L33/12 , A23L33/125 , A23L33/00
CPC分类号: A23L33/125 , A23L33/12 , A23L33/40 , A23L33/15 , A23L33/16 , A61K9/0095
-
-
公开(公告)号:EP4406557A2
公开(公告)日:2024-07-31
申请号:EP24162436.0
申请日:2011-09-26
IPC分类号: A61K47/22
CPC分类号: A61K9/0095 , A61K31/7004 , A61K31/7016 , A61K47/183 , A61P1/12 , A61K31/198 , A61K31/197 , A61K31/405 , A61K47/20 , A23V2002/0020130101 , A23V2200/3220130101 , A61K2300/0020130101 , A61K9/0053 , A61K47/22
摘要: The subject invention provides therapeutic compositions, and uses thereof for the treatment of dehydration. In preferred embodiments, the composition comprises one or more nutrients and/or electrolytes that acquire or retain considerable absorptive capacity.
-
公开(公告)号:EP4401714A1
公开(公告)日:2024-07-24
申请号:EP22870646.1
申请日:2022-09-14
申请人: Nulixir Inc.
CPC分类号: A61K36/00 , A23P10/30 , A61K31/658 , A61K9/5036 , A61K9/5161 , A61K9/0095 , A61K9/10 , A61K47/38 , A61K47/14 , A61K9/1652 , A61K45/06 , A23L33/10 , A23L33/105
-
公开(公告)号:EP4395778A1
公开(公告)日:2024-07-10
申请号:EP22777513.7
申请日:2022-08-26
发明人: POLYMEROPOULOS, Christos , POLYMEROPOULOS, Vasilios , SMIESZEK, Sandra , PRZYCHODZEN, Bartlomiej , BIRZNIEKS, Gunther , POLYMEROPOULOS, Mihael
CPC分类号: A61K31/4439 , A61K45/06 , A61P31/00 , A61P31/14 , A61K9/1623 , A61K9/0095 , A61K9/10 , G01N2800/5220130101 , G01N33/9406 , G01N2800/1220130101 , G01N2800/2620130101
-
-
-
-
-
-
-
-
-